Votrient 400mg

What is Votrient 400mg?

Votrient 400mg is pazopanib, a kinase inhibitor, sold in India under the Votrient brand name by GlaxoSmithKline Pharmaceuticals Ltd. Each tablet contains pazopanib 400 mg.

What it is used for

According to the EMA product information for Votrient (EU), pazopanib is used for advanced renal cell carcinoma (a kidney cancer) in adults, either as first treatment or after cytokine treatment, and certain forms of advanced soft tissue sarcoma in adults who have had chemotherapy for spread disease or whose cancer progressed within 12 months of treatment given before or after their main treatment. The US label carries a boxed warning that severe and fatal liver damage has been seen with pazopanib, so liver function must be checked during treatment. Your doctor decides whether it suits you.

Packs and price

Votrient 400mg comes in packs of 30, 60 and 90 tablets. The lowest price works out at about $7.43 per tablet on the 90 tablet pack, as of October 2026; the pack selector shows the current price. Shipping is $25 on orders under $149 and free from $149.

Prescription status

Pazopanib is a prescription medicine in the US, UK, Australia and Canada. The 400 mg tablet is an EU strength; US tablets come as 200 mg. Votrient 400mg itself is an Indian market pack and is not approved by the FDA, MHRA, TGA or Health Canada. The FDA says that importing unapproved medicines for personal use is illegal in most circumstances, so check the rules where you live.

Before you order

Read the patient leaflet that comes with the pack. Tell your doctor or pharmacist about any other medicines you take and any health conditions you have. Get urgent medical help if you notice signs of an allergic reaction, such as swelling of the face, lips, tongue or throat, trouble breathing, or a widespread rash.

Delivery

Orders usually arrive in 7 to 14 business days in plain packaging, with a tracking number.